Theravance Biopharma (TBPH) Other Working Capital Changes (2013 - 2026)

Theravance Biopharma (TBPH) has 13 years of Other Working Capital Changes data on file, last reported at -$2.2 million in Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 3333.82% year-over-year to -$2.2 million in Q1 2026; TTM through Mar 2026 was -$2.2 million, a 337.38% decrease from a year earlier, with the FY2025 full-year figure at $67000.0, up 112.59% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$2.2 million, down from $5.3 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for TBPH reached as high as $4.5 million in Q4 2023 and fell as low as -$1.6 million in Q3 2023.
• Historically, Other Working Capital Changes has averaged $275058.8 across 5 years, with a median of -$144000.0 in 2024.
• Across the five-year window, Other Working Capital Changes surged 1020.35% in 2025 and plunged 3333.82% in 2026, its largest moves.
• Year by year, Other Working Capital Changes stood at -$838000.0 in 2022, then jumped by 232.82% to $1.1 million in 2023, then slumped by 151.66% to -$575000.0 in 2024, then jumped by 1020.35% to $5.3 million in 2025, then plunged by 141.55% to -$2.2 million in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$2.2 million in Q1 2026, $5.3 million in Q4 2025, and -$5.3 million in Q3 2025.